About ALLOS

Relentless commitment to oncology

The facts

Allos Therapeutics, Inc. is a biopharmaceutical company with a commitment to the development and commercialization of innovative anti-cancer therapeutics.

  • The focus: Oncology
  • Began operations: 1994
  • Headquarters: Westminster, Colorado
  • Commercial Operations: Princeton, New Jersey
  • Employees: 100+ focused on clinical development and commercial operations
  • IPO: March 2000
  • Exchange/Symbol: Nasdaq/ALTH

The fundamentals

Allos Therapeutics’ key corporate operating principles are:

  • Focus on excellence and innovation in the development and execution of our clinical programs
  • Proactively evaluate opportunities to grow our business through potential product acquisitions, partnerships, and other strategic initiatives
  • Lead with ethics and integrity to ensure quality business decisions that create value for our patients, employees, and stakeholders

The future

Allos Therapeutics is committed to addressing a variety of cancers, especially in areas of high unmet need where there are few or no current treatment options.

For more information, visit www.allos.com.